Literature DB >> 20303947

Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.

Päivi Lakkisto1, Ville Kytö, Hanna Forsten, Juha-Matti Siren, Heli Segersvärd, Liisa-Maria Voipio-Pulkki, Mika Laine, Kari Pulkki, Ilkka Tikkanen.   

Abstract

Heme oxygenase-1 (HO-1), a known cytoprotective enzyme implicated also in the cell cycle regulation and angiogenesis, exerts many of its beneficial effects through carbon monoxide (CO). We studied the roles of HO-1 and CO in cardiac regeneration after myocardial infarction. Prior to coronary artery ligation, male Wistar rats were given either cobolt protoporphyrin IX to induce HO-1 or CO-donor methylene chloride. Cardiac regeneration was assessed by immunohistochemistry and confocal microscopy. CO significantly increased the accumulation of c-kit+ stem/progenitor cells into the infarct area and induced formation of new coronary arteries by promoting a substantial differentiation of c-kit+ cells into vascular smooth muscle cells (c-kit+/GATA6+ cells). Furthermore, CO increased proliferation of cardiomyocytes in the infarct border area at 4weeks post-infarction. This suggests proliferation of newly formed cardiomyocytes derived from c-kit+ cells as 10% of c-kit+ cells expressed early cardiac marker Nkx2.5. Increased expression of hypoxia-inducible factor-1alpha (HIF-1alpha), stromal cell derived factor-1alpha (SDF-1alpha) and vascular endothelial growth factor-B (VEGF-B) were found in the infarct areas of CO-donor pretreated hearts suggesting that these factors potentially promoted the migration of c-kit+ cells into the infarct area and subsequent vasculogenesis and myocardial regeneration by CO. HO-1 increased both capillary and vascular densities, while only a small increase of c-kit+ cells was found. HO-1 upregulated SDF-1alpha, but did not have effect on HIF-1alpha and VEGF-B. In conclusion, HO-1 and CO have differential roles and mechanisms of action in cardiac regeneration. Modulation of the HO-1/CO axis may provide a novel tool for the repair of cardiac injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303947     DOI: 10.1016/j.ejphar.2010.02.050

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  33 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Authors:  Shunsuke Kawamoto; Jerald P Flynn; Qun Shi; Sana W Sakr; Jun Luo; Margaret D Allen
Journal:  Tissue Eng Part A       Date:  2011-03-23       Impact factor: 3.845

3.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

Review 4.  Vascular stem/progenitor cells: functions and signaling pathways.

Authors:  Weisi Lu; Xuri Li
Journal:  Cell Mol Life Sci       Date:  2017-09-27       Impact factor: 9.261

5.  Heme Oxygenase-1/Carbon Monoxide System and Embryonic Stem Cell Differentiation and Maturation into Cardiomyocytes.

Authors:  Hagir B Suliman; Fabio Zobi; Claude A Piantadosi
Journal:  Antioxid Redox Signal       Date:  2016-03-01       Impact factor: 8.401

6.  Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.

Authors:  Susan Cheng; Danielle Enserro; Vanessa Xanthakis; Lisa M Sullivan; Joanne M Murabito; Emelia J Benjamin; Joseph F Polak; Christopher J O'Donnell; Philip A Wolf; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2014-02-25       Impact factor: 29.983

7.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.

Authors:  Anush V Karapetyan; Yuri M Klyachkin; Samy Selim; Manjula Sunkara; Khaled M Ziada; Donald A Cohen; Ewa K Zuba-Surma; Janina Ratajczak; Susan S Smyth; Mariusz Z Ratajczak; Andrew J Morris; Ahmed Abdel-Latif
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

8.  Fenofibrate Modulates HO-1 and Ameliorates Endothelial Expression of Cell Adhesion Molecules in Systolic Heart Failure.

Authors:  Wei-Hsian Yin; Jaw-Wen Chen; Yung-Hsiang Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

9.  Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart.

Authors:  Mary Kearns-Jonker; Wangde Dai; Mirja Gunthart; Tania Fuentes; Hsiao-Yun Yeh; Paul Gerczuk; Martin Pera; Christine Mummery; Robert A Kloner
Journal:  J Stem Cell Res Ther       Date:  2012-06-07

10.  Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.

Authors:  Jun Luo; Matthew S Weaver; Baohong Cao; James E Dennis; Benjamin Van Biber; Michael A Laflamme; Margaret D Allen
Journal:  Stem Cells Transl Med       Date:  2014-04-15       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.